PetMed Historical Income Statement

PETS Stock

USD 4.76 0.02 0.42%

Historical analysis of PetMed Express income statement accounts such as Gross Profit of 72.2 M, Other Operating Expenses of 189.4 M, Cost Of Revenue of 141.9 M or Total Operating Expenses of 47.5 M can show how well PetMed Express performed in making a profits. Evaluating PetMed Express income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of PetMed Express's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining PetMed Express latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PetMed Express is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

About PetMed Income Statement Analysis

PetMed Express Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to PetMed Express shareholders. The income statement also shows PetMed investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

PetMed Express Income Statement Chart

At this time, PetMed Express' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 3.6 M in 2024, whereas Gross Profit is likely to drop slightly above 72.2 M in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Ebit

Total Revenue

Total revenue comprises all receipts PetMed Express generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of PetMed Express minus its cost of goods sold. It is profit before PetMed Express operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of PetMed Express. It is also known as PetMed Express overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from PetMed Express' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into PetMed Express current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.At this time, PetMed Express' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 3.6 M in 2024, whereas Gross Profit is likely to drop slightly above 72.2 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	78.1M	71.0M	78.6M	72.2M
Total Revenue	273.4M	256.9M	281.1M	214.1M

Gross Profit Total Revenue

PetMed Express income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.81	0.95	0.33	0.23	0.45	-0.56	-0.56	-0.48	0.37	0.63	-0.53	0.63	-0.53	-0.53	0.22	-0.66	0.83	-0.82	0.83	0.24	0.95	-0.86
Interest Expense	0.81		0.78	0.37	0.28	0.46	-0.36	-0.36	-0.29	0.4	0.54	-0.31	0.79	-0.25	-0.41	0.12	-0.37	0.98	-0.68	0.98	0.72	0.69	-0.6
Selling General Administrative	0.95	0.78		0.39	0.27	0.53	-0.59	-0.59	-0.51	0.43	0.73	-0.56	0.65	-0.56	-0.54	0.28	-0.73	0.79	-0.88	0.81	0.32	0.89	-0.76
Total Revenue	0.33	0.37	0.39		0.95	0.97	0.44	0.44	0.51	0.99	0.74	0.47	0.38	0.45	0.4	0.68	0.19	0.38	-0.17	0.27	0.33	0.08	0.02
Gross Profit	0.23	0.28	0.27	0.95		0.86	0.59	0.59	0.65	0.89	0.6	0.61	0.19	0.59	0.59	0.74	0.31	0.25	0.05	0.17	0.23	-0.01	0.03
Other Operating Expenses	0.45	0.46	0.53	0.97	0.86		0.23	0.23	0.3	0.99	0.87	0.26	0.48	0.25	0.2	0.67	-0.01	0.47	-0.36	0.39	0.37	0.22	-0.05
Operating Income	-0.56	-0.36	-0.59	0.44	0.59	0.23		1.0	0.99	0.36	-0.19	1.0	-0.29	0.99	0.93	0.22	0.92	-0.37	0.77	-0.48	-0.01	-0.73	0.63
Ebit	-0.56	-0.36	-0.59	0.44	0.59	0.23	1.0		1.0	0.36	-0.19	1.0	-0.31	0.98	0.94	0.23	0.92	-0.38	0.77	-0.49	-0.02	-0.73	0.62
Ebitda	-0.48	-0.29	-0.51	0.51	0.65	0.3	0.99	1.0		0.43	-0.12	1.0	-0.26	0.98	0.93	0.27	0.9	-0.3	0.72	-0.42	0.01	-0.66	0.56
Cost Of Revenue	0.37	0.4	0.43	0.99	0.89	0.99	0.36	0.36	0.43		0.77	0.39	0.46	0.38	0.3	0.64	0.13	0.42	-0.26	0.31	0.36	0.12	0.02
Total Operating Expenses	0.63	0.54	0.73	0.74	0.6	0.87	-0.19	-0.19	-0.12	0.77		-0.16	0.47	-0.17	-0.14	0.64	-0.42	0.53	-0.59	0.54	0.33	0.49	-0.24
Income Before Tax	-0.53	-0.31	-0.56	0.47	0.61	0.26	1.0	1.0	1.0	0.39	-0.16		-0.24	0.99	0.92	0.23	0.92	-0.32	0.74	-0.44	0.04	-0.71	0.61
Total Other Income Expense Net	0.63	0.79	0.65	0.38	0.19	0.48	-0.29	-0.31	-0.26	0.46	0.47	-0.24		-0.19	-0.43	-0.05	-0.24	0.84	-0.68	0.76	0.7	0.46	-0.32
Net Income	-0.53	-0.25	-0.56	0.45	0.59	0.25	0.99	0.98	0.98	0.38	-0.17	0.99	-0.19		0.89	0.19	0.94	-0.26	0.71	-0.38	0.14	-0.72	0.63
Income Tax Expense	-0.53	-0.41	-0.54	0.4	0.59	0.2	0.93	0.94	0.93	0.3	-0.14	0.92	-0.43	0.89		0.33	0.77	-0.47	0.81	-0.52	-0.17	-0.65	0.52
Selling And Marketing Expenses	0.22	0.12	0.28	0.68	0.74	0.67	0.22	0.23	0.27	0.64	0.64	0.23	-0.05	0.19	0.33		-0.1	0.05	-0.08	0.09	-0.02	0.12	-0.13
Net Income From Continuing Ops	-0.66	-0.37	-0.73	0.19	0.31	-0.01	0.92	0.92	0.9	0.13	-0.42	0.92	-0.24	0.94	0.77	-0.1		-0.35	0.78	-0.49	0.06	-0.81	0.7
Non Operating Income Net Other	0.83	0.98	0.79	0.38	0.25	0.47	-0.37	-0.38	-0.3	0.42	0.53	-0.32	0.84	-0.26	-0.47	0.05	-0.35		-0.74	0.97	0.7	0.7	-0.59
Tax Provision	-0.82	-0.68	-0.88	-0.17	0.05	-0.36	0.77	0.77	0.72	-0.26	-0.59	0.74	-0.68	0.71	0.81	-0.08	0.78	-0.74		-0.76	-0.36	-0.81	0.64
Interest Income	0.83	0.98	0.81	0.27	0.17	0.39	-0.48	-0.49	-0.42	0.31	0.54	-0.44	0.76	-0.38	-0.52	0.09	-0.49	0.97	-0.76		0.69	0.75	-0.65
Net Interest Income	0.24	0.72	0.32	0.33	0.23	0.37	-0.01	-0.02	0.01	0.36	0.33	0.04	0.7	0.14	-0.17	-0.02	0.06	0.7	-0.36	0.69		0.06	0.06
Reconciled Depreciation	0.95	0.69	0.89	0.08	-0.01	0.22	-0.73	-0.73	-0.66	0.12	0.49	-0.71	0.46	-0.72	-0.65	0.12	-0.81	0.7	-0.81	0.75	0.06		-0.93
Extraordinary Items	-0.86	-0.6	-0.76	0.02	0.03	-0.05	0.63	0.62	0.56	0.02	-0.24	0.61	-0.32	0.63	0.52	-0.13	0.7	-0.59	0.64	-0.65	0.06	-0.93

Click cells to compare fundamentals

PetMed Express Account Relationship Matchups

PetMed Express income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	2.3M	2.4M	2.7M	3.5M	7.1M	7.4M
Interest Expense	2.9M	1.2M	335K	3.0M	3.5M	3.6M
Selling General Administrative	25.3M	28.3M	30.8M	49.5M	55.2M	58.0M
Total Revenue	284.1M	309.2M	273.4M	256.9M	281.1M	214.1M
Gross Profit	81.2M	89.9M	78.1M	71.0M	78.6M	72.2M
Other Operating Expenses	253.1M	271.6M	247.7M	258.3M	289.2M	189.4M
Operating Income	31.0M	37.6M	25.7M	(1.4M)	(8.2M)	(7.8M)
Ebit	31.0M	37.6M	25.7M	(1.4M)	(7.5M)	(7.1M)
Ebitda	33.2M	40.0M	28.4M	2.1M	(394K)	(374.3K)
Cost Of Revenue	202.9M	219.3M	195.3M	185.8M	202.4M	141.9M
Total Operating Expenses	50.3M	52.4M	52.4M	72.4M	86.8M	47.5M
Income Before Tax	33.9M	39.2M	27.1M	1.6M	(6.3M)	(6.0M)
Total Other Income Expense Net	2.9M	1.6M	1.4M	3.0M	1.9M	2.0M
Net Income	25.9M	23.9M	18.7M	233K	(7.5M)	(7.1M)
Income Tax Expense	8.0M	8.6M	6.0M	1.4M	1.2M	1.1M
Selling And Marketing Expenses	22.7M	21.6M	18.8M	19.4M	24.5M	23.4M
Net Income Applicable To Common Shares	25.9M	30.6M	21.1M	233K	268.0K	254.6K
Net Income From Continuing Ops	25.9M	30.6M	21.1M	233K	(7.5M)	(7.1M)
Non Operating Income Net Other	2.9M	1.6M	1.4M	3.0M	3.5M	3.6M
Tax Provision	8.0M	8.6M	6.0M	1.4M	1.2M	1.1M
Interest Income	1.7M	314K	335K	2.1M	2.4M	2.5M
Net Interest Income	1.7M	314K	335K	2.1M	511K	485.5K
Reconciled Depreciation	2.3M	2.4M	2.7M	3.5M	7.1M	7.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PetMed Historical Income Statement

About PetMed Income Statement Analysis

PetMed Express Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

PetMed Express income statement Correlations

PetMed Express Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PetMed Express income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for PetMed Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Cost Of Revenue	+ 0.99	Total Revenue

Extraordinary Items	- 0.93	Reconciled Depreciation
Tax Provision	- 0.88	Selling General Administrative
Extraordinary Items	- 0.86	Depreciation And Amortization
Tax Provision	- 0.82	Depreciation And Amortization
Reconciled Depreciation	- 0.81	Tax Provision
Reconciled Depreciation	- 0.81	Net Income From Continuing Ops